Hepatotoxicity as dose-limiting toxicity of the combination of bosutinib and atezolizumab in patients with chronic myeloid leukemia. Results of the ZEROLMC study
Article in Annals of Hematology (April 2024)
The most recent citing publications are shown below. View all 2 publications that cite this research output on Dimensions.
Article in Annals of Hematology (April 2024)
Article in Frontiers in Oncology (July 2023)